logo

Analyst Comments: Kirkland, MetLife, Incyte Biotech, Patni Computer, Akamai Technologies
By: Zacks Investment Research   Friday, August 01, 2008 10:00 PM

Vote for next session
The next market session will close:

Kirkland's Weathering the Storm

Kirkland's, Inc. (KIRK) shares are up 111% year-to-date and have rewarded those buyers who were bottom fishing at much lower levels. We continue to applaud Kirkland's for taking the necessary steps to weather the current storm by focusing on cash flow and closing its unprofitable stores. Moreover, we believe the company's second-quarter results will benefit from higher gross margins and cost controls and are narrowing our quarterly net loss estimate.

However, we are less sanguine about the company's prospects for the second half of the year. Macro headwinds will continue to pressure consumer discretionary spending, and the consumer will not be helped out by those $600 tax rebate checks, as they were in the second quarter. Until we see evidence of the macro conditions improving, we believe it makes sense to take profits in KIRK shares. As such, we are downgrading Kirkland's from a Buy to a Hold.

Companies in the home furnishings space will continue to retrench and focus on cash management, while waiting for industry conditions to improve. Inventory management will remain a focus for Kirkland's and should reduce the need to borrow on its revolving credit line. The company has shifted into cash conservation mode by closing 30 stores in January and planning to close another 40 stores in 2008. Including those store closures, Kirkland's has 108 stores with expiring leases in the next 18 months, which it can exit at no cash cost.

The valuation of stocks in the home furnishings industry is depressed across the board. Kirkland's trades at a slight discount to its industry peers based on price-to-book, price-to-sales, and price-to-cash flow ratios. We think this discount is reasonable because Kirkland's is much smaller than its peers and see a fair value at $2.25 or 25x our 2009 EPS estimate.


MetLife with Market Headwinds

MetLife Inc.'s (MET) second quarter operating earnings came in at $1.30 per share, substantially below the estimates, due primarily to a decline in equity markets and higher catastrophe losses in its homeowners business. Net income for the quarter fell 19% year-over-year, due to a spike in investment losses, which overshadowed the 10% growth in the top-line.

After reviewing second quarter results, we have moderated our FY08 and FY09 operating earnings estimates to $5.82 per share and $6.43 per share, respectively. Shares of MetLife currently trade at 1.23 times its 2Q08 reported book value of $41.98 per share, a 2% discount to the peer group median.

Relative pricing looks fair on a price-to-book basis, given a ROE about 1% below the peer group median. We expect MET to continue strong growth in the International and Institutional Business segments, which will be somewhat offset by the decline in investment income.


Next Page >>123

(2)
 
8/21/2008 3:02:50 AM
CSS News by Pitter
Nice blog site.
Rating: (0) (0)
8/21/2008 3:02:50 AM
CSS News by Pitter
Nice blog site.
Rating: (0) (0)
Post Comment
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
   
 
 
 
 
   
 

The above story is the opinion of the author only and it does not reflect iStockAnalyst opinion. Further, the author is not personally advising you regarding the suitability of the story for your investment needs. In no event iStockAnalyst will be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from or arising out of, or in connection with the use of this information. Please consult your investment advisor before making any investment decision.
  
Advertisement
Popular Articles
Related Press Releases
Advertisement
Partner Center
Recent Articles by Zacks Investment Research



Subscribe to Email Alerts rss feed or RSS feeds rss feed for articles from more than 500 contributors, press releases, SEC filings and full text news from more than four thousand sources.
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia